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ABSTRACT We present an improved monomeric form of the red ﬂuorescent protein, mRFP1, as the acceptor in biological
ﬂuorescence resonance energy transfer (FRET) experiments using the enhanced green ﬂuorescent protein as donor. We ﬁnd
particular advantage in using this ﬂuorophore pair for quantitative measurements of FRET using multiphoton ﬂuorescence
lifetime imaging microscopy (FLIM). The technique was exploited to demonstrate a novel receptor-kinase interaction between
the chemokine receptor (CXCR4) and protein kinase C (PKC) a in carcinoma cells for both live- and ﬁxed-cell experiments. The
CXCR4-EGFP: PKCa-mRFP1 complex was found to be localized precisely to intracellular vesicles and cell protrusions when
imaged by multiphoton ﬂuorescence-FLIM. A comparison of the FRET efﬁciencies obtained using mRFP1-tagged regulatory
domain or full-length PKCa as the acceptor revealed that PKCa, in the closed (inactive) form, is restrained from associating with
the cytoplasmic portion of CXCR4. Live-cell FLIM experiments show that the assembly of this receptor:kinase complex is
concomitant with the endocytosis process. This is conﬁrmed by experimental evidence suggesting that the recycling of the
CXCR4 receptor is increased on stimulation with phorbol ester and blocked on inhibition of PKC by bisindolylmaleimide. The
EGFP-mRFP1 couple should be widely applicable, particularly to live-cell quantitative FRET assays.
INTRODUCTION
Measurement of the near-ﬁeld localization of protein
complexes may be achieved by the detection of ﬂuorescence
(or Fo¨rster) resonance energy transfer (FRET) between
protein-conjugated ﬂuorophores. FRET is a nonradiative,
dipole-dipole coupling process, whereby energy from an
excited donor ﬂuorophore is transferred to an acceptor
ﬂuorophore in close proximity (Fo¨rster, 1948). The de-
pendence of the coupling efﬁciency varies with the inverse-
sixth power of the distance between acceptor and donor and
is typically described in terms of the Fo¨rster radius (distance
at which the efﬁciency of energy transfer is 50%), typically
of the order 1–10 nm. Excitation of the donor sensitizes
emission from the acceptor that ordinarily would not occur.
Since the process depletes the excited state population of the
donor, FRET will both reduce the ﬂuorescence intensity and
the ﬂuorescence lifetime of the donor. The efﬁciency of energy
transfer may be used as a molecular scale ruler to determine
the interaction scale of a particular interaction (Stryer, 1978).
Expressible ﬂuorophore-coupled protein partners for FRET
are necessary to investigate protein-protein interactions in
live cultured cells and ultimately in vivo. In the context of
imaging the dynamics of intermolecular interactions in cells
(when the FRET donor and acceptor are on two separate
protein molecules rather than a fused chimera), an accurate
assessment of the proportion of donor ﬂuorophore-labeled
protein molecules that undergo FRET at each cell pixel is
desirable.
Fluorescence lifetime imaging microscopy (FLIM) is
a well-established technique for studying spatiotemporal
protein-protein interactions in situ through the detection of
FRET between protein-bound ﬂuorophores (Anilkumar et al.,
2003; Gadella and Jovin, 1995; Herreros et al., 2001; Legg
et al., 2002; Ng et al., 2001, 1999a,b; Parsons et al., 2002).
For intermolecular FRET a key advantage of donor FLIM is
that ﬂuorescence-lifetime measurements of donor emission
are essentially independent of acceptor concentration (assum-
ing excess acceptor) and is therefore well suited to studies in
intact cells (see, for example, Bastiaens and Pepperkok, 2000;
Ng et al., 1999b; Parsons et al., 2004; Peter and Ameer-Beg,
2004; Wouters et al., 2001). Combined with confocal or
multiphoton microscopic techniques to examine the localiza-
tion of effects in cellular compartments, FLIM/FRET tech-
niques allow us to determine populations of interacting protein
species on a point-by-point basis at each resolved voxel in the
cell (Becker et al., 2001). Time-correlated single-photon
counting (TCSPC) is a mature technique that exploits the
quantum nature of light to recover the ﬂuorescence lifetime of
a ﬂuorophore by statistical analysis of the arrival times of
photons with respect to a reference (i.e., the excitation pulse)
(O’Connor and Phillips, 1984). FLIM analysis can be
enhanced by application of global analysis (i.e., assumption
of globally invariant ﬂuorescence lifetime components and
calculation over all available data sets, or pixels) to data
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obtained using either time-domain (Beechem and Brand,
1986; Beechem and Haas, 1989) or frequency domain-based
methodology (Verveer and Bastiaens, 2003; Verveer et al.,
2000a,b, 2001). The spatially invariant lifetimes are assumed
to pertain to the donor molecular species in the presence or
absence of FRET, the relative amplitudes of the two
components being proportional to the molar fractions of the
two species. In the case of protein events that take place in
localized regions or speciﬁc organelles of the cell, acquisition
of ﬂuorescence lifetimes by two-photon excitation, single-
photon excitation through a confocal aperture or ﬂuorescence
deconvolution (Bastiaens and Pepperkok, 2000; Neil et al.,
2000; Schonle et al., 2000; Squire and Bastiaens, 1999)
enhances the sensitivity of FRET detection, by removing the
contribution of noninteracting species in out-of-plane regions.
There are both advantages and disadvantages to using any
of the existing pairs of EGFP mutants in donor FLIM/FRET
assays and this has been the subject of a number of review
articles (Miyawaki, 2003; Periasamy, 2001; Pollock and
Heim, 1999; Selvin, 2000). In brief, for the most commonly
used CFP-YFP pair, CFP alone may exhibit bi-exponential
decay kinetics when observed in the cellular environment
(Tramier et al., 2002), making quantitative analysis of an
interacting FRET population impractical. Recent reports of
an improved variant of CFP, the Cerulean (Rizzo et al.,
2004), show an encouraging improvement in its photo-
physical parameters (quantum yield and extinction co-
efﬁcient). Cerulean is reported to have a monoexponential
ﬂuorescence decay in vitro, and provided that these kinetics
can be reproduced with different biological constructs in
cells, this new variant will serve as a good alternative to
EGFP when employed in donor FLIM assays. Other
ﬂuorescent protein variants suffer from additional problems
such as photo-instability for the BFP-EGFP pair (Ellenberg
et al., 1998). In addition, there is a substantial emission cross
talk due to spectral overlap for the most widely used CFP-
YFP pair, complicating quantiﬁcation of FRET efﬁciency by
intensity-based methods (Gordon et al., 1998). Given the
signiﬁcant Stokes shift between the CFP and YFP emission,
acceptor emission cross talk for donor-FLIM can be
eliminated with judicious choice of interference ﬁlters at
the expense of photon-efﬁcient collection. This problem is,
however, exacerbated by the 4.9-fold increase in brightness
(deﬁned by quantum yield multiplied by extinction co-
efﬁcient) between CFP and YFP (Patterson et al., 2001).
There has been interest in improving the current
techniques through the use of red bioﬂuorescent proteins
HcRed and DsRed (Lippincott-Schwartz and Patterson,
2003; Zhang et al., 2002). DsRed has been used successfully
with EGFP in limited applications (Erickson et al., 2003;
Mizuno et al., 2001). However, HcRed and DsRed exist in
oligomeric complexes, which can inhibit both protein
distribution and function. For example, when fused to the
gap function protein Cx43 (Campbell et al., 2002) and when
fused with calmodulin (Mizuno et al., 2001), DsRed has
been consistently observed to form perinuclear red ﬂuores-
cent aggregates. The recently reported (Campbell et al.,
2002) monomeric variant of DsRed (mRFP1) has a signiﬁ-
cant advantage over its progenitor, since it does not form
oligomers and matures rapidly with little or no green com-
ponent in its ﬂuorescence emission. The low quantum efﬁ-
ciency reported for mRFP1 makes it less advantageous as
a FRET acceptor when used in intensity-based methodolo-
gies. However, since the emissive behavior of the acceptor
has little or no effect on the measurement of FRET by donor
FLIM, mRFP1 makes a likely candidate as an acceptor for
EGFP or YFP donors in lifetime-based assays.
The chemokine receptor CXCR4 has been implicated in
promoting the migratory phenotype of a variety of tumors
including breast, prostate, and pancreatic cancers, as well as
myeloma and several tumors of hematopoietic origin
(reviewed by Moore, 2001). CXCR4 is found to be con-
sistently upregulated in human breast cancer cells relative to
its level in normal mammary epithelial cells (Muller et al.,
2001). Stromal-cell-derived factor 1, the ligand for CXCR4,
is expressed at high levels in all target organs for breast
cancer metastasis and at low levels in all other organs.
CXCR4 undergoes endocytosis after ligand binding or pro-
tein kinase C (PKC) activation by phorbol esters (Guinamard
et al., 1999; Signoret et al., 1997, 1998). The C-terminal
domain of CXCR4, which contains several putative PKCa
phosphorylation sites, is required for its endocytosis. We
have identiﬁed and characterized a phorbol ester-induced
CXCR4:PKCa complex in the endosomal structures of
MDA-MB-231 breast carcinoma cells, using FRET detection
by multiphoton FLIM (between CXCR4-EGFP and PKCa-
mRFP1).
MATERIALS AND METHODS
Cell culture
Human breast carcinoma MDA-MB-231 cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium containing 10% fetal calf serum at 37C, in a 10%
CO2 atmosphere. MDA-MB-231 cells were transfected with the CXCR4-
EGFP plasmid (see below) with Lipofectamine Plus (Gibco Invitrogen,
Carlsbad, CA). 48 h after transfection was initiated, cells were replated in
complete medium at 1:5 ratio. Selection for neomycin resistance was started
the following day by the addition of the antibiotic G-418 (Calbiochem, San
Diego, CA) at 1 mg/ml. CXCR4-EGFP expressing cells were enriched by
ﬂuorescence-activated cell sorting. After 10–14 days, G418-resistant cells
were isolated as a mixed clone and subsequently maintained in complete
growth medium containing 1 mg/ml G418. Stable transfectants were
cultured for up to 20 passages.
Plasmid constructs
The EGFP-tagged CXCR4 construct was obtained by subcloning the
CXCR4 coding sequence into the HindIII and EcoRI sites of the pEGFP-N1
(Clontech, Palo Alto, CA). mRFP1 was obtained from Professor R. Tsien
and cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA). Full-length or
regulatory domain (RD) (aa 1–337) PKCa-mRFP1 was generated by
subcloning the PKCa coding sequence into the NheI and EcoRI sites of
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pcDNA-mRFP1. PKCa-DsRed was similarly constructed for the purpose of
direct comparison.
CXCR4 recycling assay
Live MDA-MB-231 cells stably expressing CXCR4-EGFP and plated on
coverslips were either left untreated at 37C or incubated with media
containing 10 mM bisindolylmaleimide (BIM) (Calbiochem) or 1 mM
primaquine (Sigma-Aldrich, Poole, Dorset, UK). After 1 h, the cells were
incubated with media containing 10 mg/ml of anti-CXCR4 monoclonal
antibody (12G5) (R&D Systems, Minneapolis, MN) for 20 min to label both
the plasma membrane and internal pools of the receptor, and subsequently
washed with PBS to remove the excess antibody. To examine the effect of
phorbol ester on the recycling, 1 mM PDBu (Sigma-Aldrich) was added to
the media containing the anti-CXCR4 antibody. All cells were then
incubated for 2 min in cold culture media adjusted to pH 4.0 to remove cell
surface antibody as described (Signoret et al., 1997, 1998). Subsequently
this low pH media was washed out, replaced by pH 7.4 media, and the cells
were returned to 37C. At different time points, cells were stained with an
anti-mouse Cy-5 conjugated antibody (Jacksons Immunoresearch Labora-
tories, West Grove, PA) at 4C for 20 min to label the pool of receptors that
had recycled back to the membrane, then ﬁxed in 4% paraformaldehyde/
PBS for 30 min. For cells treated with BIM or primaquine, the inhibitor was
maintained throughout the experiment.
Cell microinjection, ﬁxation, and preparation
MDA-MB-231 cells stably expressing CXCR4-EGFP were microinjected
using a FEMTOJET microinjection system (Eppendorf UK Ltd., Histon,
Cambridge, UK). After 16 h, cells were either imaged immediately using
a multiphoton ﬂuorescence-FLIM system equipped with a cabinet incubator
or ﬁxed in 4% (w/v) paraformaldehyde for 30 min and permeabilized with
0.2% (v/v) Triton X-100/PBS. Coverslips were ﬁnally prepared with
Mowiol Mounting Medium (ICN, Costa Mesa, CA) containing 2.5% (w/v)
1,4-diazabicyclo (2.2.2) octane (Sigma-Aldrich) as an antifade reagent.
Confocal microscopy
Confocal images were acquired with a confocal laser-scanning microscope
(LSM 510, Carl Zeiss, Jena, Germany) equipped with a 633/1.4 Plan-
Apochromat oil immersion objective. Z-series data were acquired by
interline scanning for EGFP (488 nm excitation; 510 nm emission) and
mRFP1 (514 nm excitation; 600 nm emission), respectively. The confocal
aperture was set to one Airy unit for the longest wavelength (typically
0.7 mm). Each image represents a two-dimensional projection of two or
three slices in the Z-series, taken across the cell at 0.2-mm intervals.
Absorption and ﬂuorescence
emission measurements
Absorption spectra were taken with an 8452A diode array spectrophotom-
eter (Hewlett-Packard, Palo Alto, CA). The ﬂuorescence spectra were
measured with an LS 50B (Perkin-Elmer, Boston, MA) at a resolution of
5 nm.
Time-resolved multiphoton microscopy
All FLIM measurements were undertaken with a 403 (1.3 NA) Nikon Plan-
Fluor oil objective lens on a modiﬁed multiphoton microscopy system which
has been described previously (Ameer-Beg et al., 2002, 2003). In brief, the
system consists of a MRC1024 MP dual confocal/multiphoton system
(BioRad Microscience, Hemel Hempstead, UK) coupled to a TE200
inverted microscope (Nikon, Tokyo, Japan). Time-resolved detection is
afforded by the addition of a non-descanned detection channel with a fast
photomultiplier and SPC700 time-correlated single-photon counting elec-
tronics (Becker and Hickl GmbH, Berlin, Germany). Either a 500 6 20 nm
or 600 6 20 nm bandpass ﬁlter was used in the detector channel (Coherent,
Santa Clara, CA). Laser power was adjusted to give average photon counting
rates of the order 104–105 photons s1 (0.0001–0.001 photons/excitation
event) and with peak rates approaching 106 photons s1, below the
maximum counting rate afforded by the TCSPC electronics to avoid pulse
pile-up. Acquisition times of the order of 300 s at low excitation power
were used to achieve sufﬁcient photon statistics for ﬁtting, while avoiding
either pulse pile-up or signiﬁcant photobleaching. Excitation was at 890 nm
for EGFP-mRFP1 samples and at 980 nm for mRFP1 lifetime measure-
ments.
Analysis of time-resolved ﬂuorescence data for
FRET experiments
In analysis of FRET data (particularly for protein-interaction applications),
there are usually two elements that must be considered—interacting
ﬂuorophore population and FRET efﬁciency. Bulk measurements of
FRET efﬁciency (i.e., intensity-based methods) cannot distinguish between
an increase in FRET efﬁciency (i.e., coupling efﬁciency) and an increase in
FRET population (concentration of FRET species) since the two parameters
are not resolved. Measurements of FRET based on analysis of the
ﬂuorescence lifetime of the donor may resolve this dichotomy when
analyzed using multi-exponential decay models. The assumption that
noninteracting and interacting fractions are present allows us to determine
both the efﬁciency of interaction and the fractional population of interacting
population. Such an approach may be extended from a pixel-by-pixel
analysis (where we make no spatial restraints on the ﬁtting parameters) to
analysis of all pixels globally under the assumption that the FRET efﬁciency
is constant across all pixels (i.e., global analysis; Verveer et al., 2000a).
In the ﬁrst instance, the presence/absence of FRET is determined by
ﬁtting of the experimental data to a single-exponential decay. Sufﬁcient
reduction in the measured lifetime indicates FRET, and since the interactions
are intermolecular, we perform additional analysis to determine the source of
lifetime reduction. In this instance, we apply a bi-exponential ﬂuorescence
decay model to the data to determine the ﬂuorescence lifetime of nonin-
teracting and interacting subpopulations. The data may be ﬁt by iterative
re-convolution to
IðtÞ ¼
Z N
N
IinstrðtÞfZ1a1Expðt=t1Þ1a2Expðt=t2Þgdt;
(1)
where Iinstr is the instrumental response, Z is the baseline offset, t1 and t2 are
lifetimes of the interacting/noninteracting populations, and a1 and a2 are
the pre-exponential factors relating to absolute species concentration. The
fractional proportions of the two populations, f1 and f2, are related to the
absolute concentration via the relationships
f1 ¼ a1=ða11a2Þ and f2 ¼ a2=ða11a2Þ: (2)
The reduced goodness-of-ﬁt parameter, x2r , is used as deﬁned by
Lakowicz (1999) as
x
2
r ¼ +
n
k¼1
½IðtkÞ  IcðtkÞ2=IðtkÞ
 
ðN  pÞ; (3)
where I(tk) is the data and Ic(tk) the ﬁt value at the k
th time point, tk. N is the
number of time points and p the number of variable ﬁt parameters. The value
x2r is minimized using a modiﬁed Marquardt algorithm and compared
alongside plots for the weighted residuals (R ¼ (I(tk)–Ic(tk))/I(tk)) to de-
termine the validity of the decay model.
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Given the level of uncertainty in determining all of the free parameters
using this model, we use a minimally restrained system of ﬁtting to
determine both the interaction efﬁciency and population. By ﬁxing the
noninteracting species lifetime using data obtained from control experiments
(in the absence of FRET), more accurate estimations of the remaining free
parameters may be made. Furthermore, by assuming invariance in the
efﬁciency of interaction between pixels throughout the measured cell one
can determine the interaction efﬁciency by summation of data throughout
the cell and thereby ﬁx both lifetime parameters for single pixel ﬁtting.
The FRET efﬁciency is related to the molecular separation of donor and
acceptor and the ﬂuorescence lifetime of the interacting fraction by
hfret ¼ R60= R601 r6
   ¼ 1 tfret=td; (4)
where R0 is the Fo¨rster radius, R the molecular separation, tfret is the lifetime
of the interacting fraction, and td the lifetime of the donor in the absence of
acceptor. Clearly in this instance we can also take tfret and td to be the
lifetimes of the interacting fraction and noninteracting fraction, respectively.
For measurements of bulk interactions (i.e., where only single-exponential
decays are ﬁt to the data), measured efﬁciencies will appear signiﬁcantly
lower due to the, possibly incorrect, assumption that all donors are
associated with one or more acceptors. Where a multi-exponential model is
assumed, partially interacting subpopulations may be identiﬁed distinctly
from the bulk response. The caveat to this is that sufﬁciently high photon
counts are required to resolve these complex dynamics.
RESULTS AND DISCUSSION
Monomeric red ﬂuorescent protein (mRFP1) as
a FRET acceptor
We have compared mRFP1 with the more commonly used
ﬂuorescent protein pair used for FRET experiments CFP-
YFP in Fig. 1 A. Fluorescent proteins (His-tagged) encoded
by pRSET vectors were expressed in bacteria and puriﬁed
using Ni-NTA-agarose (Qiagen, Valencia, CA) as per
manufacturer’s protocol. The spectra for the CFP-YFP pair
were kindly provided by Dr. V. Subramaniam (AstraZeneca,
Luton, Bedfordshire, UK) for the purpose of comparison.
There is substantially less spectral emission overlap between
the EGFP-mRFP1 pair in comparison to CFP-YFP, leading
to more relaxed spectral ﬁltering (or indeed more straightfor-
ward spectral un-mixing). For measurements of FRET by
FLIM we and others (Tramier et al., 2002) have observed
multi-exponential decay kinetics for CFP even in the absence
of an acceptor (Fig. 1 B and Table 1). In this example, the
ﬂuorescent proteins were fused to IkB and p65 (protein
components of the NF-kB transcription pathway) which are
complexed constitutively (Morton et al., 2003). If a mono-
exponential model (giving a single lifetime t) is used to ﬁt
the decay kinetics either in the absence or presence of the
YFP acceptor, we ﬁnd that x2 is increased and modulation is
observed in the residuals: a clear indication that a bi-
exponential model is more appropriate in both cases. Al-
though the average ﬂuorescence lifetime may be employed
to determine the presence of FRET (and the average FRET
efﬁciency), no quantitative information on the molar con-
centration of conjugated proteins can be reasonably re-
covered (in situ) since this would require ﬁtting of at least
four exponential components and superlative photon statis-
tics (and by inference unacceptably long acquisition times).
We have also observed the CFP moiety to be susceptible to
modiﬁcation in lifetime in the presence of external stimulus
(i.e., tumor necrosis factor a (Morton et al., 2003). Unfor-
tunately, the reportedly low quantum yield of ;0.25 of
mRFP1 does not make it an ideal acceptor for use in
intensity-based FRET measurements. However, this should
not preclude its use for either donor ﬂuorescence quenching
or acceptor photobleaching methods.
As a ﬂuorescent probe for functional biology, mRFP1
confers a number of advantages over the DsRed progenitor;
FIGURE 1 (A) Emission spectra of cyan (CFP), yellow (YFP), enhanced
green (EGFP), and monomeric red (mRFP1) ﬂuorescent-protein variants.
(B) Fluorescence transients for CFP in the absence (I) and presence (II) of
FRET.
EGFP-mRFP FRET Using Multiphoton FLIM 1227
Biophysical Journal 88(2) 1224–1237
it matures rapidly, exhibits negligible green ﬂuorescence,
and is less inhibitory to protein function. In illustration, the
decay kinetic of the ﬂuorescence at 500 6 20 nm of PKCa-
DsRed is shown to be bi-exponential (data accumulated from
a region inside transfected cells) in Fig. 2 A and Table 2.
Even in the absence of FRET, the measurement of CXCR4-
EGFP lifetime can be contaminated with the 0.4-ns
component of the green emission from DsRed (Fig. 2 B
and Table 2). Furthermore, the excitation and emission
spectral properties of DsRed are complex, ﬂuorescence
correlation spectroscopy data suggesting that there might be
at least three interconvertible states, apparently ﬂuorescent,
with different excitation and emission properties (Malvezzi-
Campeggi et al., 2001). In contrast to the DsRed data the
mRFP1 probe does not produce signiﬁcant green ﬂuores-
cence after the maturation phase and, when used in con-
junction with EGFP, no cross talk is observed in situ. The
ﬂuorescence lifetime of mRFP1 observed at 600 6 20 nm
is given in Fig. 3. We observe a single-exponential decay
(as conﬁrmed by both x2r and analysis of residuals) with
a lifetime of 2.05 6 0.1 ns.
Estimation of the Fo¨rster radius for
EGFP-mRFP1 interaction
To calculate the Fo¨rster radius for the interaction between
EGFP and mRFP1 we undertook spectroscopic measure-
ments (Fig. 4) of the absorption and emission of mRFP1 and
EGFP, respectively. The peak emission of mRFP1 is shifted
from 583 nm to 607 nm relative to DsRed, conferring
a modest advantage for ﬁltering when co-expressed with
either EGFP or YFP. Unfortunately, this may be offset in
FRET experiments by the concomitant reduction in the
Fo¨rster radius. The secondary peak in the absorption
spectrum corresponds to a primarily nonradiative state and
therefore does not appear on the excitation spectra (data not
shown) but is signiﬁcant in the context of calculation of the
spectra overlap and Fo¨rster radius. This feature of the
mRFP1 photophysics contributes signiﬁcantly to the sub-
optimal conditions for intensity-based FRET assays using
this probe. The spectral overlap integral was calculated from
Lakowicz (1999) as
JðlÞ ¼
Z N
0
FDðlÞeAðlÞl4dl
Z N
0
FDðlÞdl; (5)
where FD(l) is the corrected ﬂuorescence intensity of the
donor with the total intensity (area under the curve)
TABLE 1 Fluorescence decay analysis for cyan and yellow
ﬂuorescent proteins (from Fig. 1 B)
Proteins t1 (ns) f1 t2 (ns) f2 x
2
CFP control
1.78 6 0.2 30.9
0.36 6 0.08 0.32 6 0.05 2.29 6 0.05 0.68 6 0.05 1.26
CFP/YFP
1.12 6 0.2 35.2
0.33 6 0.10 0.49 6 0.05 1.58 6 0.15 0.51 6 0.05 1.88
FIGURE 2 Individual transient decays for two-photon excitation at 890 nm and emission at 500 nm (620 nm), indicating contamination of the measurement
of CXCR4-EGFP in the presence of full-length PKCa-DsRed in unstimulated cells. (A) PKCa-DsRed, bi-exponential kinetics are indicated. (B) CXCR4-
EGFP alone; single-exponential kinetics are observed. (C) PKCa-DsRed and CXCR4-EGFP, Kinetics observed are contaminated with the fast component of
PKCa-DsRed.
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normalized to unity. The value eA is the extinction coefﬁcient
of the acceptor at l (in units M1cm1). The Fo¨rster radius
(R0) is then given by
R0 ¼ 0:2113 101½k2n4QD JðlÞ1=6 ðnmÞ; (6)
where n is the refractive index, QD is the ﬂuorescence
quantum yield of the donor, and k is a parameter relating to
the orientation of donor and acceptor. Assuming that the
dipoles of the acceptor are randomly oriented with respect to
the donor we take the k2 ¼ 2/3. The refractive index is taken
to be that of water (n ¼ 1.3). The quantum efﬁciency of
EGFP was taken to be 0.6 (Patterson et al., 1997) and the
molar extinction coefﬁcient for mRFP1 to be 44,000 cm1
M1 (Campbell et al., 2002). By inserting these values into
Eq. 5 we obtain a Fo¨rster radius of 4.7 6 0.5 nm. This is
comparable to that calculated for CFP-YFP (4.9–5.2 nm;
Tsien, 1998) and EGFP-DsRed (4.71–5.76 nm; Erickson
et al., 2003). The estimation of R0 at the lower end of what is
expected for DsRed is due to the 25-nm Stokes shift in
absorption which leads to slightly less favorable spectral
overlap, the more distinct absorption band-shape of mRFP1
(smaller spectral half-width), and the 1.3-fold reduction in
molar extinction coefﬁcient (note that there is some two-to-
threefold discrepancy in the literature regarding the extinc-
tion coefﬁcient of DsRed, almost certainly due to the
complex nature of the excited state and the slow maturation
of the red species (Erickson et al., 2003 and references
therein). There may be some future advantage in substituting
the EGFP donor for the red-shifted variant YFP to increase
the Fo¨rster radius without signiﬁcant degradation in the
spectral ﬁltering between donor and acceptor. However, we
foresee the greatest possible advantage from further mutation
of mRFP1 to produce variants with higher quantum yields
(and/or increased extinction coefﬁcient) to more fully exploit
intensity-based methods for FRET assays.
Highly localized FRET between EGFP-CXCR4
and mRFP1-PKCa
Recently, a novel protein-signaling complex involved in the
control of breast cancer cell motility was identiﬁed bio-
chemically between the chemokine receptor CXCR4, and the
N-terminal regulatory domain (RD) of PKCa in breast
carcinoma cells (M. Peter and T. Ng, unpublished data). To
conﬁrm this interaction in situ, FRET experiments were
performed between an EGFP-labeled construct of CXCR4
(CXCR4-EGFP) and an mRFP1-conjugated, full-length
PKCa (PKCa-mRFP1). The ﬂuorescence lifetime (assum-
ing a single-exponential decay) in CXCR4-EGFP stably
transfected cells was measured in the presence or absence of
PKCa-mRFP1 expressed through nuclear microinjection of
an expression plasmid (Fig. 5). For both control (PKCa-
mRFP1 negative) and co-expressing cells (PKCa-mRFP1
positive) we observe no signiﬁcant reduction in the ﬂuores-
cence lifetime of EGFP suggesting that little or no short-
range interaction occurs under quiescent conditions. In
FIGURE 3 Transient decay for PKCa-mRFP1 by two-photon excitation,
and emission at 980 nm and 600 nm (620 nm), respectively, exhibiting
single-exponential kinetics.
TABLE 2 Fluorescence decay analysis for EGFP and DsRed
(from Fig. 2)
Proteins t1 (ns) f1 t2 (ns) f2 x
2
DsRed
1.88 6 0.4 6.72
2.10 6 0.05 0.65 0.43 6 0.05 0.35 1.25
eGFP
2.08 6 0.05 1.09
2.21 6 0.05 0.8 1.63 6 0.05 0.2 1.11
GFP/DsRed
2.04 6 0.2 4.27
2.17 6 0.05 0.79 0.46 6 0.05 0.21 1.13
FIGURE 4 Emission and absorption spectra of EGFP and mRFP1,
respectively, from protein extract solutions.
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contrast, after stimulation with phorbol ester (phorbol di-
butyrate, PDBu), the ﬂuorescence lifetime is observed to
reduce signiﬁcantly throughout the cell relative to the stimu-
lated, uninjected control cells (Fig. 5 A). Critical analysis of
the data (examination of the residuals and x2r ) indicates that
a bi-phasic decay model is more appropriate suggesting the
presence of interacting and noninteracting protein popula-
tions. Assuming the interaction distance to be constant, we
found the invariant lifetimes of the two decay species were
0.956 0.1 ns (EGFP species undergoing FRET) and 2.206
0.05 ns (EGFP species not undergoing FRET). This cor-
responds to a population-resolved FRET efﬁciency of
0.57 6 0.05 or an interaction distance of ;4.48 nm (be-
tween ﬂuorescent proteins at N-termini andwithin the assump-
tions made for the determination of the Fo¨rster radius). Fixing
these two lifetime parameters for each pixel we can resolve
the fractional contribution of the FRET species (Fig. 5 A).
The N-terminal regulatory region of PKCa has several
functional domains (Parker and Murray-Rust, 2004). The C1
domain contains a Cys-rich motif that forms the phorbol
ester binding site. The C2 domain contains the recognition
site for acidic lipids and the Ca21 binding site. An
autoinhibitory pseudosubstrate sequence (PS) precedes C1.
When PKCa is inactive, the PS domain is bound to the
C-terminal kinase region of PKCa. Phorbol esters serve as
hydrophobic anchors to recruit PKCa to the membrane.
Moreover, phorbol esters induce the removal of the PS
sequence from the PKCa kinase core (Nelsestuen and Bazzi,
1991). PKCa is then in an open conformation, unmasking
various potential cryptic binding site(s) in the regulatory
domain to its binding partners.
We postulate that before the addition of phorbol ester, the
closed conformation of the conventional PKC isozyme
PKCa is unfavorable for CXCR4 binding. Upon activation
by phorbol ester PKCa assumes a more open conformation,
allowing its RD to interact with CXCR4. This hypothesis is
FIGURE 5 (A) Images of cells co-expressing CXCR4-EGFP and full-
length PKCa-mRFP1 with or without phorbol ester treatment. The
microinjected PKCa-positive red ﬂuorescent cells are indicated in each
panel (red arrows). Increased FRET populations were observed in the
vesicular compartment and ﬁlopodial cell protrusions (white arrows). The
intensity image for the 1ve PDBu panel is taken from confocal data and
shows regions of co-localization between CXCR4-EGFP (red) and PKCa-
mRFP1 (green). (B) Images of cells expressing CXCR4-EGFP with
regulatory domain (RD) PKCa-mRFP1 spanning amino acid residues
1–337 (RD (aa 1–337) PKCa-mRFP1) and the associated RD (aa 1–337)
PKCa-mRFP1 negative control. The 1ve RD (aa 1–337) PKCa-mRFP1
intensity image is taken from confocal data and shows colocalization of
CXCR4-EGFP (green) and RD (aa 1–337) PKCa-mRFP1 (red). Donor
lifetime images and the corresponding FRET population cell map in the
presence of RD (aa 1–337) PKCa-mRFP1, where ﬁtting with a bi-
exponential decay model is possible are shown. The ﬁeld of view was
chosen such that the lifetime map of the microinjected 1ve RD (aa 1–337)
PKCa-mRFP1 cell could be compared to an adjacent ve RD (aa 1–337)
PKCa-mRFP1 cell. (C) Images of cells co-expressing CXCR4-EGFP and
full-length PKCa-DsRed with or without phorbol ester treatment. Confocal
images show PKCa-DsRed (red) aggregates that do not colocalize with
CXCR4-EGFP (green) but indicate a short lifetime component that con-
taminates each lifetime map. No increase in association/FRET is observed
in the presence of PDBu.
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partly based on our ﬁnding of a physical overlap, within
PKCa, between the CXCR4 interaction site and the phorbol-
binding domain (M. Peter and T. Ng, unpublished data). The
phorbol-binding domain has been shown to be rendered
inaccessible by at least two inhibitory intramolecular
interactions in conventional PKCs before activation (Oancea
and Meyer, 1998; Slater et al., 2002). These FLIM data
conﬁrm that CXCR4-EGFP can be induced to associate with
full-length PKCa-mRFP1 after stimulation with PDBu with
good co-localization observed between the two proteins in
the membrane and vesicular compartments (Fig. 5 A). The
highest concentration of FRET species was localized to
ﬁlopodial structures (white arrows) and large vesicular
clusters. The large clusters containing low lifetime FRET
species (marked with a red arrow) may represent receptor-
kinase complexes that are associated with clathrin and its
associated adaptor proteins in clathrin-coated vesicles
(Brown and Petersen, 1998).
These experiments were repeated for comparison with
DsRed as acceptor. Full-length PKCa-DsRed was found to
display an abnormal aggregation pattern, apparent in
unstimulated cells (Fig. 5 C) in contrast to the diffuse
cytosolic distribution of full-length PKCa-mRFP1. The
ﬂuorescence lifetime observed in the presence of PKCa-
DsRed (in the absence of stimulation) is contaminated (as
previously discussed) with a fast lifetime component such
that the clusters containing a high concentration of DsRed
have anomalously low lifetimes. In the presence of PDBu,
full-length PKCa-DsRed does not appear to associate with
CXCR4-EGFP (no lifetime reduction occurs relative to the
control) in contrast to the earlier result. We conclude that
PKCa-DsRed is biologically inactive and a poor choice as
a FRET acceptor in this instance.
To address the mechanism of the effect of phorbol ester
we compared the data obtained using mRFP1-tagged RD
(RD (aa 1–337) PKCa-mRFP1) to those of the full-length
PKCa as the acceptor. Unlike the full-length PKCa-mRFP1
that was found to be cytosolic and does not co-localize to any
signiﬁcant degree with CXCR4-EGFP in quiescent cells, the
RD construct is localized predominantly to membrane and
vesicular structures (Fig. 5 B). We ﬁnd that the ﬂuorescence
lifetime is reduced from the control for cells containing the
RD (aa 1–337) PKCa-mRFP1 construct. Further analysis of
the data revealed the presence of at least two ﬂuorescent
species and ﬁtting to a bi-exponential model was performed
assuming invariant lifetimes. The lifetimes were found to be
2.16 0.05 ns and 1.26 0.2 ns, respectively, similar to those
observed for full-length PKCa upon stimulation. Localiza-
tion of the highest concentration of FRET species to intra-
cellular vesicular structures is particularly evident in the
fractional contribution (FRET population) cell map Fig. 5 B.
The population-resolved FRET efﬁciency (43%) for RD
(aa 1–337) PKCa-mRFP1, which does not have an in-
hibitory domain, indicates that this construct interacts
constitutively with CXCR4. These data suggest that, in the
closed form, PKCa is conformationally restrained from
associating with the cytoplasmic portion of CXCR4. The
observed effect of phorbol ester on the receptor-kinase
complex formation is probably due to a phorbol ester-
induced opening of the inhibitory conformation leading to an
unmasking of the CXCR4 binding site in PKCa.
To further analyze the intracellular distribution of the
CXCR4-EGFP FRET species, a series of two-photon excited
ﬂuorescence lifetime image slices was taken in the z plane at
1-mm intervals toward the dorsal surface of the cell starting
from the cell coverslip interface (marked 0 mm in Fig. 6). At
this pixel resolution (128 3 128 at 1 mm/pixel) it is hard to
resolve individual vesicles but it is clear that areas of locally
reduced lifetimes correspond to a subset of the clustered
intracellular vesicles. This was not found to be due to
concentration-dependent quenching when compared to
similar controls (ve PKCa (RD1V3)mRFP). We
observe that the CXCR4-EGFP species were noticeably
more perinuclear in their distribution as we moved toward
the dorsal surface of the cell. In an effort to demonstrate the
variable degree of GFP-mRFP1 FRET among vesicles of
similar EGFP intensity (i.e., concentration-independent), we
recorded the ﬂuorescence lifetime for those vesicles that
could be individually resolved by thresholding in intensity
(to isolate the vesicle) and then summing photon counts over
the vesicle. The results of this are shown in Fig. 7 A where
we observe a vesicle lifetime histogram which shows
a distinct shift from the 2.1- to 2.2-ns lifetime observed for
control cells. Plotting the scattergram of ﬁtted peak intensity
values (i.e., a in Eq. 1) versus lifetime (Fig. 7 B) we observe
no obvious correlation between short lifetime measurement
and peak intensity, indicating that the reduction in lifetime is
not due to concentration-dependent quenching of EGFP in
the vesicles. The distinct localization of the FRET species
to these vesicles does not, however, demonstrate whether
the EGFP-CXCR4:mRFP1-PKCa complexes are preformed
on vesicles and transported to the plasma membrane or
assembled in response to endocytosis of the chemokine
receptor. A live-cell experiment was therefore performed to
address this mechanistic issue.
In situ dynamics of CXCR4-EGFP and
PKCa-mRFP1 interaction
One of the key advantages in using expressible probes for
FRET experiments is the ability to measure dynamic events
in live cells. We have performed exemplar multiphoton
ﬂuorescence-FLIM measurements using live cells in an
incubation chamber attached to a multiphoton microscope to
observe the association of CXCR4-EGFP with PKCa-
mRFP1 after stimulation with PDBu. Cells, stably express-
ing CXCR4-EGFP were cultured on glass-bottomed cell
culture dishes (MatTek, Ashland, MA) and transiently
transfected with PKCa-mRFP1 and allowed to express
over a period of 36 h. Growth media was replaced with 37C
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phenol red free media and transported to the microscope
incubator where they were allowed to equilibrate for ;30
min. Controls with cells expressing both CXCR4-EGFP and
PKCa-mRFP1 were observed for 1 min acquisitions at 0, 5,
10, 15, and 20 min to check for phototoxicity at a laser power
of 1–2 mW (data not shown). The control experiment in
Fig. 8 A (CXCR4-EGFP alone) was performed using a wider
ﬁeld of view than for the mRFP1 positive cells to allow
cell-by-cell quantitation of the ﬂuorescence lifetime (i.e.,
cell-to-cell variation was minimal). We did not observe any
signiﬁcant photobleaching or morphological changes in the
imaged cells to indicate short-term damage due to these
exposures. For live cells in media we observe control life-
times for CXCR4-EGFP of the order of 2.46 0.1-ns slightly
longer than observed for ﬁxed cells. In agreement with the
experiments performed using ﬁxed cells we observed no
FIGURE 6 Series of two-photon excited ﬂuorescence lifetime image slices of 1-mm separation in the z plane toward the dorsal surface of a cell co-expressing
CXCR4-EGFP and RD (aa 1–337) PKCa-mRFP1. The perinuclear concentration of FRET species is more apparent in the dorsal sections (arrows).
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signiﬁcant FRET between CXCR4-EGFP and PKCa-
mRFP1 in the cytoplasmic areas of the cell before addition
of PDBu (Fig. 8, 1 min). However, some reduction in
lifetime was observed in the vesicular structures indicative of
basal level activity in the cell. After addition of PDBu, we
observed a signiﬁcant morphological change to the cells
within a few minutes as the cell appears to round up while
remaining attached to the coverslip. Refocusing after 5 min
a signiﬁcant portion of CXCR4 has internalized to form large
vesicular structures (as observed for ﬁxed cells) with
a signiﬁcantly reduced ﬂuorescence lifetime. By 20 min
we are almost certainly viewing the base of the cell below the
nucleus with the images showing large vesicular aggregates
indicating reduced lifetime and, by inference, FRET and
protein interaction. It is possible that the vesicle environment
modiﬁes the EGFP lifetime (this may be particularly true if
the environment is acidic). However, we observe a lifetime
of 2.38 6 0.05 ns for mRFP1 negative cells (Fig. 8 A) after
;25 min of PDBu treatment compared to 2.176 0.03 ns for
mRFP1 positive cells. The effect of addition of PDBu can be
seen clearly in the images at each time point and is conﬁrmed
by the histograms of FRET efﬁciency shown in Fig. 8 C for
1 and 20 min (taking into account the effects of both local
environment and phorbol treatment on the mRFP1 negative
control). We see a distribution of FRET efﬁciency values
peaking ;0.1–0.15, signiﬁcantly greater than the observed
basal level of ,0.05. These results indicate that, as phorbol
ester induces endocytosis of the CXCR4 receptor to form
large vesicular clusters (as shown in ﬁxed cells, Fig. 5 A),
there is a signiﬁcant increase in the proportion of CXCR4-
EGFP that is complexed to PKCa-mRFP1. The assembly of
this receptor:kinase complex is therefore demonstrated to be
FIGURE 7 (A) Vesicle lifetime histogram comprising vesicles from
throughout the cell in Fig. 6. (B) Scattergram of ﬁtted vesicle amplitude
versus lifetime showing no correlation between vesicle intensity and mea-
sured lifetime.
FIGURE 8 Time course of protein-protein interaction after stimulation
with PDBu in live cells. (A) Control time sequence CXCR4-EGFP alone,
showing no reduction in ﬂuorescence lifetime as a function of time. (B) Cells
imaged under the same conditions as A, during PDBu stimulation in the
presence of both CXCR4-EGFP and PKCa-mRFP1. The ﬂuorescence
lifetime is reduced particularly in the vesicular inclusions. (C) Histogram of
FRET efﬁciency for the stimulated cells in B using the control lifetime
derived from A as the divisor in Eq. 4.
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a phorbol ester-induced signaling response which is con-
comitant with the process of endocytosis.
To further conﬁrm the signiﬁcance of these results,
CXCR4 recycling experiments were performed to examine
the effect of both stimulation and inhibition of PKC on the
recycling rate. The experiments were performed as described
in Materials and Methods and the results are summarized in
Fig. 9. Stimulation with PDBu (Fig. 9, D–F) appears to
increase the rate of recycling of CXCR4 to the membrane
compared to the unstimulated control by confocal imaging
(Fig. 9, A–C). This increase in recycling is biologically
signiﬁcant in terms of its effect on the recovery of receptor
function after downregulation through endocytosis. To make
objective comparison between experimental conditions,
images of cells at each time point were thresholded slightly
above background and the average pixel value taken
corresponding to the cellular membrane and the values
normalized to the full scale and plotted as a function of time
(Fig. 9 G). Inhibition of PKC by bisindolylmaleimide (BIM)
appears to abolish recycling over the timescale of the ex-
periment to a similar extent to that observed with primaquine,
a potent inhibitor for membrane transport from the endo-
somes to the plasma membrane (van Weert et al., 2000.).
These results suggest that the relationship between PKCa
and CXCR4 is highly signiﬁcant in the context of endocytic
recruitment and recycling.
CONCLUSION
In this article we have demonstrated that the combination of
EGFP and mRFP1 offers advantages over the currently
available FRET pairs with a speciﬁc biological interaction (a
novel receptor:kinase complex). Both ﬂuorescent proteins
are genetically encodable, their emission spectra are well
separated and mRFP1 is monomeric, reducing the possibility
of protein function inhibition. We have calculated the Fo¨rster
radius for the EGFP:mRFP1 pair to be ;4.7 nm, which is
comparable to that of CFP:YFP (4.9 nm). When calculating
the Fo¨rster radius, we had assumed the refractive index to be
that of water, n ¼ 1.3, which is close to that of cytoplasm
(Johnsen and Widder, 1999). The higher refractive index of
lipids (in the membrane lipid bilayer for instance) of ;n ¼
1.48, could account for some of the heterogeneity of
CXCR4-EGFP lifetimes in cells that do not express
PKCa-mRFP1 (Suhling et al., 2002) and marginally reduce
the Fo¨rster radius to 4.35 nm. However, one would expect an
increase in ﬂuorescence lifetime for increasing refractive
index (due to reduction in the nonradiative decay rate). In
contrast we observe a minor decrease in the ﬂuorescence
lifetime, suggesting that the effect may be due more to local
reduction in pH than the increased refractive index (EGFP
has been shown to be sensitive to pH; Heikal et al., 2001;
Kneen et al., 1998). Despite this, we show that the shortening
of EGFP lifetimes due to EGFP:mRFP1 energy transfer is of
such extent that it is easily distinguished from the variation
of EGFP lifetimes due to local environmental effects.
We were able to conﬁrm the DsRed-induced aggregation
using a PKCa fusion construct as has been previously
reported for other proteins such as calmodulin (Mizuno et al.,
2001). Similarly, the ability of PKCa to translocate to the
membrane upon phorbol ester treatment is impaired by
tagging with the tetrameric DsRed. The lack of membrane
localization can only partially account for the perturbation of
protein function since the dimeric mutants of DsRed (tdimer
and dimer2) do not affect the membrane localization and yet
still perturb the gap junction formation function of Connexin
43 (Campbell et al., 2002).
High spatial resolution imaging in ﬁxed cells combined
with the determination of ﬂuorescence lifetime changes in
real time in live cells have provided us important addi-
tional insights into the mechanisms of phorbol-ester in-
duced CXCR4:PKCa complex formation. In live cells, as
phorbol ester induces endocytosis of the CXCR4 receptor
FIGURE 9 Time course of endocytic recycling measured by selective
immunolabeling of CXCR4 at the plasma membrane, for (A–C) unstimu-
lated cells and (D–F) cells stimulated with PDBu. The pixel intensity of cells
under a variety of experimental conditions are plotted versus time (G) to
show increased recycling of CXCR4 at the membrane under stimulation
with PDBu and retardation of the recycling process after BIM or primaquine
treatment.
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to internalize into large vesicular clusters, we observe
a signiﬁcant increase in the proportion of CXCR4-EGFP
that is complexed to PKCa-mRFP1. The assembly of this
receptor:kinase complex is therefore likely to represent
a signaling process that is concomitant with the process of
endocytosis, and not the transcytosis of preformed com-
plexes to the plasma membrane. Moreover, we show that
when the receptor is endocytosed in the presence of a PKC
activator, the rate of receptor recycling to the plasma
membrane is signiﬁcantly increased. This increase in
recycling is important biologically in terms of its effect on
the recovery of receptor, function after downregulation
through endocytosis. PKCs have previously been shown to
regulate the endocytosis and recycling of the integrin family
of extracellular matrix receptors (Ng et al., 1999a; Roberts
et al., 2001). Here we show for the ﬁrst time that the
recycling of a chemotactic receptor is enhanced concomi-
tantly with the formation of a kinase-receptor complex in
endosomes. Also, it was shown that dynamic actin-rich
comet tails appeared on a subset of cytoplasmic vesicles that
were enriched in PKC and the Wiskott-Aldrich syndrome
proteins (speciﬁcally N-WASP; Taunton, 2001; Taunton
et al., 2000). Together these data suggest that the signiﬁcance
of PKC binding/recruitment to the CXCR4 receptor is to
stimulate a focal actin polymerization, which generates
a physical force that propels the internalized endosome. The
concept of a signaling endosome assembly is relatively
established with another integral membrane receptor, the
epidermal growth factor (EGF) receptor (Seto et al., 2002).
After binding of its ligand, EGF, a variety of signaling
molecules are recruited to the activated receptor complex.
Likewise elements of the clathrin-mediated endocytosis
machinery are recruited and serve to promote the formation
of clathrin-coated vesicles containing the ligand-bound
receptor associated with signaling molecules (Bivona and
Philips, 2003). This endomembrane compartment therefore
represents a point of convergence of molecular machinery in
signaling and endocytosis. Further characterization of the
spatiotemporal composition of the CXCR4-mediated signal-
ing endosome using similar biophysical approaches may
provide new insights for understanding the poorly un-
derstood relationship among receptor trafﬁcking, signaling,
and cancer cell behavior (Polo et al., 2004).
When used in combination with two-photon TCSPC
imaging, EGFP:mRFP1 offers a quantitative, high-resolution
assessment of protein-protein interactions in situ both
spatially and temporally. These advantages should make
this ﬂuorophore pair widely applicable particularly to live-
cell FRET/FLIM assays.
We are grateful to Prof. Roger Tsien for the kind gift of the mRFP1 in the
bacterial expression vector pRSET. We thank Julian Gilbey, Rosalind
Locke, and Paul Barber for their work on the donor-ﬂuorescence data
collection and analysis program, which we used to analyze some of the
data. We are indebted to Dr. Vinod Subramaniam (AstraZeneca) for
providing the spectra for the eCFP-eYFP pair for the purposes of
comparison.
Marion Peter is a recipient of a Human Frontier Science Program Long-
Term Fellowship. Borivoj Vojnovic and Simon Ameer-Beg acknowledge
the support of the Cancer Research UK (under program grant C133/
A1812), Research Councils UK, Basic Technology Program, and the Paul
Instrument Fund of the Royal Society. This work would not be possible
without the technical support of the GCI electronics and mechanical
workshops.
REFERENCES
Ameer-Beg, S. M., P. R. Barber, R. J. Hodgkiss, R. J. Locke, R. G.
Newman, G. M. Tozer, B. Vojnovic, and J. Wilson. 2002. Application of
multiphoton steady-state and lifetime imaging to mapping of tumour
vascular architecture in vivo. Proc SPIE. 4620:85–95.
Ameer-Beg, S. M., N. Edme, M. Peter, P. R. Barber, and T. B. V. Ng. 2003.
Imaging protein-protein interactions by multiphoton FLIM. Proc. SPIE.
5139:180–189.
Anilkumar, N., M. Parsons, R. Monk, T. Ng, and J. C. Adams. 2003.
Interaction of fascin and protein kinase Ca: a novel intersection in cell
adhesion and motility. EMBO J. 22:5390–5402.
Bastiaens, P. I., and R. Pepperkok. 2000. Observing proteins in their natural
habitat: the living cell. Trends Biochem. Sci. 25:631–637.
Becker, W., K. Benndorf, A. Bergmann, C. Biskup, K. Ko¨nig, U. Tirlapur,
and T. Zimmer. 2001. FRET measurements by TCSPC laser scanning
microscopy. Proc. SPIE. 4431:414–419.
Beechem, J. M., and L. Brand. 1986. Global analysis of ﬂuorescence decay:
applications to some unusual experimental and theoretical studies.
Photochem. Photobiol. 44:323–330.
Beechem, J. M., and E. Haas. 1989. Simultaneous determination of
intramolecular distance distributions and conformational dynamics by
global analysis of energy transfer measurements. Biophys. J. 55:1225–
1236.
Bivona, T. G., and M. R. Philips. 2003. Ras pathway signaling on
endomembranes. Curr. Opin. Cell Biol. 15:136–142.
Brown, C. M., and N. O. Petersen. 1998. An image correlation analysis of
the distribution of clathrin associated adaptor protein (AP-2) at the
plasma membrane. J. Cell Sci. 111:271–281.
Campbell, R. E., O. Tour, A. E. Palmer, P. A. Steinbach, G. S. Baird, D. A.
Zacharias, and R. Y. Tsien. 2002. A monomeric red ﬂuorescent protein.
Proc. Natl. Acad. Sci. USA. 99:7877–7882.
Ellenberg, J., J. Lippincott-Schwartz, and J. F. Presley. 1998. Two-color
green ﬂuorescent protein time-lapse imaging. Biotechniques. 25:838–
846.
Erickson, M. G., D. L. Moon, and D. T. Yue. 2003. DsRed as a potential
FRET partner with CFP and GFP. Biophys. J. 85:599–611.
Fo¨rster, T. 1948. Intermolecular energy migration and ﬂuorescence. Annals
Phys. 6:55–75.
Gadella, T. W., Jr., and T. M. Jovin. 1995. Oligomerization of epidermal
growth factor receptors on A431 cells studied by time-resolved
ﬂuorescence imaging microscopy. A stereochemical model for tyrosine
kinase receptor activation. J. Cell Biol. 129:1543–1558.
Gordon, G. W., G. Berry, X. H. Liang, B. Levine, and B. Herman. 1998.
Quantitative ﬂuorescence resonance energy transfer measurements using
ﬂuorescence microscopy. Biophys. J. 74:2702–2713.
Guinamard, R., N. Signoret, M. Ishiai, M. Marsh, T. Kurosaki, J. V.
Ravetch, and I. Masamichi. 1999. B cell antigen receptor engagement
inhibits stromal cell-derived factor (SDF)-1a chemotaxis and promotes
protein kinase C (PKC)-induced internalization of CXCR4. J. Exp. Med.
189:1461–1466.
Heikal, A. A., S. T. Hess, and W. W. Webb. 2001. Multiphoton molecular
spectroscopy and excited state dynamics of enhanced green ﬂuorescent
protein (EGFP): acid-base speciﬁcity. Chem. Phys. 274:37–55.
EGFP-mRFP FRET Using Multiphoton FLIM 1235
Biophysical Journal 88(2) 1224–1237
Herreros, J., T. Ng, and G. Schiavo. 2001. Lipid rafts act as specialized
domains for tetanus toxin binding and internalization into neurons. Mol.
Biol. Cell. 12:2947–2960.
Johnsen, S., and E. A. Widder. 1999. The physical basis of transparency in
biological tissue: ultrastructure and the minimization of light scattering.
J. Theor. Biol. 199:181–198.
Kneen, M., J. Farinas, Y. Li, and A. S. Verkman. 1998. Green ﬂuorescent
protein as a noninvasive intracellular pH indicator. Biophys. J. 74:1591–
1599.
Lakowicz, J. 1999. Principles of ﬂuorescence spectroscopy. Kluwer
Academic/Plenum Publishers, New York.
Legg, J. W., C. A. Lewis, M. Parsons, T. Ng, and C. M. Isacke. 2002. A
novel PKC-regulated mechanism controls CD44 ezrin association and
directional cell motility. Nat. Cell Biol. 4:399–407.
Lippincott-Schwartz, J., and G. H. Patterson. 2003. Development and use of
ﬂuorescent protein markers in living cells. Science. 300:87–91.
Malvezzi-Campeggi, F., M. Jahnz, K. G. Heinze, P. Dittrich, and P.
Schwille. 2001. Light-induced ﬂickering of DsRed provides evidence for
distinct and interconvertible ﬂuorescent states. Biophys. J. 81:1776–
1785.
Miyawaki, A. 2003. Visualisation of the spatial and temporal dynamics of
intracellular signaling. Dev. Cell. 4:295–305.
Mizuno, H., A. Sawano, P. Eli, H. Hama, and A. Miyawaki. 2001. Red
ﬂuorescent protein from Discosoma as a fusion tag and a partner for
ﬂuorescence resonance energy transfer. Biochemistry. 40:2502–2510.
Moore, M. A. 2001. The role of chemoattraction in cancer metastases.
Bioessays. 23:674–676.
Morton, P. E., T. C. Ng, S. A. Roberts, B. Vojnovic, and S. M. Ameer-Beg.
2003. Time-resolved multiphoton imaging of the interaction between the
PKC and the NFkB cell signalling pathway. Proc. SPIE. 5139:216–
222.
Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T.
McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Barrera, A.
Mohar, E. Verastegui, and A. Zlotnik. 2001. Involvement of chemokine
receptors in breast cancer metastasis. Nature. 410:50–56.
Neil, M. A., A. Squire, R. Juskaitis, P. I. Bastiaens, and T. Wilson. 2000.
Wide-ﬁeld optically sectioning ﬂuorescence microscopy with laser
illumination. J. Microsc. 197:1–4.
Nelsestuen, G. L., and M. D. Bazzi. 1991. Activation and regulation of
protein kinase C enzymes. J. Bioenerg. Biomembr. 23:43–61.
Ng, T., M. Parsons, W. E. Hughes, J. Monypenny, D. Zicha, A. Gautreau,
M. Arpin, S. Gschmeissner, P. J. Verveer, P. I. Bastiaens, and Peter J.
Parker. 2001. Ezrin is a downstream effector of trafﬁcking PKC-integrin
complexes involved in the control of cell motility. EMBO J. 20:2723–
2741.
Ng, T., D. Shima, A. Squire, P. I. Bastiaens, S. Gschmeissner, M. J.
Humphries, and P. J. Parker. 1999a. PKCa regulates b1 integrin-
dependent cell motility through association and control of integrin trafﬁc.
EMBO J. 18:3909–3923.
Ng, T., A. Squire, G. Hansra, F. Bornancin, C. Prevostel, A. Hanby, W.
Harris, D. Barnes, S. Schmidt, H. Mellor, P. I. Bastiaens, and P. J.
Parker. 1999b. Imaging protein kinase Ca activation in cells. Science.
283:2085–2089.
Oancea, E., and T. Meyer. 1998. Protein kinase C as a molecular machine
for decoding calcium and diacylglycerol signals. Cell. 95:307–318.
O’Connor, D. V., and D. Phillips. 1984. Time Correlated Single Photon
Counting. Academic Press, London, UK.
Parker, P. J., and J. Murray-Rust. 2004. PKC at a glance. J. Cell Sci.
117:131–132.
Parsons, M., S. M. Ameer-Beg, and B. Vojnovic. 2004. Imaging protein-
protein interactions in cell motility using FRET. Biochem. Soc. Trans.
32:431–433.
Parsons, M., M. D. Keppler, A. Kline, A. Messent, M. J. Humphries, R.
Gilchrist, I. R. Hart, C. Quittau-Prevostel, W. E. Hughes, P. J. Parker,
and T. Ng. 2002. Site-directed perturbation of protein kinase C-integrin
interaction blocks carcinoma cell chemotaxis. Mol. Cell. Biol. 22:5897–
5911.
Patterson, G., R. N. Day, and D. Piston. 2001. Fluorescent protein spectra.
J. Cell Sci. 114:837–838.
Patterson, G. H., S. M. Knobel, W. D. Sharif, S. R. Kain, and D. W. Piston.
1997. Use of the green ﬂuorescent protein and its mutants in quantitative
ﬂuorescence microscopy. Biophys. J. 73:2782–2790.
Periasamy, A. 2001. Fluorescence resonance energy transfer microscopy:
a mini review. J. Biomed. Opt. 6:287–291.
Peter, M., and S. M. Ameer-Beg. 2004. Imaging molecular interactions by
multiphoton FLIM. Biol. Cell. 96:231–236.
Pollock, B. A., and R. Heim. 1999. Using GFP in FRET-based applications.
Trends Cell Biol. 9:57–60.
Polo, S., S. Pece, and P. P. Di Fiore. 2004. Endocytosis and cancer. Curr.
Opin. Cell Biol. 16:156–161.
Rizzo, M. A., G. H. Springer, B. Granada, and D. W. Piston. 2004. An
improved cyan ﬂuorescent protein variant useful for FRET. Nat.
Biotechnol. 22:445–449.
Roberts, M., S. Barry, A. Woods, P. van der Sluijs, and J. Norman. 2001.
PDGF-regulated rab4-dependent recycling of avb3 integrin from early
endosomes is necessary for cell adhesion and spreading. Curr. Biol. 11:
1392–1402.
Schonle, A., M. Glatz, and S. W. Hell. 2000. Four-dimensional multiphoton
microscopy with time-correlated single-photon counting. Appl. Optics.
39:6306–6311.
Selvin, P. R. 2000. The renaissance of ﬂuorescence resonance energy
transfer. Nat. Struct. Biol. 7:730–734.
Seto, E. S., H. J. Bellen, and T. E. Lloyd. 2002. When cell biology meets
development: endocytic regulation of signaling pathways. Genes Dev.
16:1314–1336.
Signoret, N., J. Oldridge, A. Pelchen-Matthews, P. J. Klasse, T. Tran, L. F.
Brass, M. M. Rosenkilde, T. W. Schwartz, W. Holmes, W. Dallas, and
M. A. Luther, T. N. Wells, J. A. Hoxie, and M. Marsh. 1997. Phorbol
esters and SDF-1 induce rapid endocytosis and down-modulation of the
chemokine receptor CXCR4. J. Cell Biol. 139:651–664.
Signoret, N., M. M. Rosenkilde, P. J. Klasse, T. W. Schwartz, M. H.
Malim, J. A. Hoxie, and M. Marsh. 1998. Differential regulation of
CXCR4 and CCR5 endocytosis. J. Cell Sci. 111:2819–2830.
Slater, S. J., J. L. Seiz, A. C. Cook, C. J. Buzas, S. A. Malinowski, J. L.
Kershner, B. A. Stagliano, and C. D. Stubbs. 2002. Regulation of PKCa
activity by C1–C2 domain interactions. J. Biol. Chem. 277:15277–
15285.
Squire, A., and P. I. Bastiaens. 1999. Three-dimensional image restoration
in ﬂuorescence lifetime imaging microscopy. J. Microsc. 193:36–49.
Stryer, L. 1978. Fluorescence energy transfer as a spectroscopic ruler. Ann.
Rev. Biochem. 47:819–846.
Suhling, K., J. Siegel, D. Phillips, P. M. French, S. Leveque-Fort, S. E.
Webb, and D. M. Davis. 2002. Imaging the environment of green
ﬂuorescent protein. Biophys. J. 83:3589–3595.
Taunton, J. 2001. Actin ﬁlament nucleation by endosomes, lysosomes and
secretory vesicles. Curr. Opin. Cell Biol. 13:85–91.
Taunton, J., B. A. Rowning, M. L. Coughlin, M. Wu, R. T. Moon, T. J.
Mitchison, and C. A. Larabell. 2000. Actin-dependent propulsion of
endosomes and lysosomes by recruitment of N-WASP. J. Cell Biol.
148:519–530.
Tramier, M., I. Gautier, T. Piolot, S. Ravalet, K. Kemnitz, J. Coppey, C.
Durieux, V. Mignotte, and M. Coppey-Moisan. 2002. Picosecond-hetero-
FRET microscopy to probe protein-protein interactions in live cells.
Biophys. J. 83:3570–3577.
Tsien, R. Y. 1998. The green ﬂuorescent protein. Annu. Rev. Biochem.
67:509–544.
van Weert, A. W., H. J. Geuze, and W. S. B. Groothuis. 2000. Primaquine
interferes with membrane recycling from endosomes to the plasma
membrane through a direct interaction with endosomes which does not
1236 Peter et al.
Biophysical Journal 88(2) 1224–1237
involve neutralisation of endosomal pH nor osmotic swelling of
endosomes. Eur. J. Cell Biol. 79:394–399.
Verveer, P. J., and P. I. Bastiaens. 2003. Evaluation of global analysis
algorithms for single frequency ﬂuorescence lifetime imaging micros-
copy data. J. Microsc. 209:1–7.
Verveer, P. J., A. Squire, and P. I. Bastiaens. 2000a. Global analysis of
ﬂuorescence lifetime imaging microscopy data. Biophys. J. 78:2127–
2137.
Verveer, P. J., A. Squire, and P. I. Bastiaens. 2001. Improved spatial
discrimination of protein reaction states in cells by global analysis and
deconvolution of ﬂuorescence lifetime imaging microscopy data.
J. Microsc. 202:451–456.
Verveer, P. J., F. S. Wouters, A. R. Reynolds, and P. I. Bastiaens. 2000b.
Quantitative imaging of lateral ErbB1 receptor signal propagation in the
plasma membrane. Science. 290:1567–1570.
Wouters, F. S., P. J. Verveer, and P. I. Bastiaens. 2001. Imaging
biochemistry inside cells. Trends Cell Biol. 11:203–211.
Zhang, J., R. E. Campbell, A. Y. Ting, and R. Y. Tsien. 2002. Creating new
ﬂuorescent probes for cell biology. Nat. Rev. Mol. Cell Biol. 3:
906–918.
EGFP-mRFP FRET Using Multiphoton FLIM 1237
Biophysical Journal 88(2) 1224–1237
